Position in DNLI
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$4,124,922
+$1,646,106 QoQ
Shares Held
160,378
+24.2% QoQ
Ownership
0.100%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#72
of 290 holders
Holding Since
Jun 2022
17 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in DNLI Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026ALPS ADVISORS INC holds $213,436,831 across 115 Biotechnology names. DNLI ranks #12 (1.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RPRX |
Royalty Pharma plc
|
315,335 | $17,680,833 | |
| 2 | APGE |
Apogee Therapeutics, Inc.
|
62,523 | $8,298,677 | |
| 3 | CGON |
CG Oncology, Inc.
|
89,218 | $6,338,938 | |
| 4 | XENE |
Xenon Pharmaceuticals Inc.
|
97,610 | $5,891,739 | |
| 5 | ORKA |
Oruka Therapeutics, Inc.
|
61,014 | $5,806,702 | |
| 6 | DNTH |
Dianthus Therapeutics, Inc. /DE/
|
55,281 | $5,388,791 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
93,981 | $5,339,060 | |
| 8 | DFTX |
Definium Therapeutics, Inc.
|
110,388 | $5,192,651 |
All Filings in DNLI
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,124,922 | 160,378 | Shares | Defined | 2026-07-29 | |
| 2026-03-31 | $2,478,816 | 129,105 | Shares | Defined | 2026-05-08 | |
| 2025-12-31 | $1,993,054 | 120,718 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $1,019,739 | 70,230 | Shares | Defined | 2025-11-05 | |
| 2025-06-30 | $1,096,200 | 78,356 | Shares | Defined | 2025-08-11 | |
| 2025-03-31 | $1,514,143 | 111,375 | Shares | Defined | 2025-04-30 | |
| 2024-12-31 | $2,371,763 | 116,377 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $3,094,975 | 106,247 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $2,582,969 | 111,239 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $2,014,017 | 98,149 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $2,102,264 | 97,962 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $2,091,882 | 101,400 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $2,969,296 | 100,620 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $2,074,636 | 90,045 | Shares | Defined | 2023-05-10 | |
| 2022-12-31 | $2,559,326 | 92,029 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $2,066,142 | 67,323 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $2,146,624 | 72,940 | Shares | Defined | 2022-08-15 | |
| No filing history on record for this holder in this stock. | ||||||